|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Mar―14 |
Covid-19 research evidence: An international survey exploring views on useful sources, preferred formats, and accessibility |
Eve Tomlinson, Debra De Silva, Jana Stojanova, Roses Parker, Muriah Umoquit, Stephanie Lagosky, et al. (+2) Bey-Marrié Schmidt, Karen Head |
2 |
[GO] |
2022―Mar―08 |
A literature review on COVID-19 [coronavirus] research specific to Australia including manuscripts on policy and media releases. |
Deborah Joy Hilton |
3 |
[GO] |
2021―Aug―27 |
From SARS to COVID-19: lessons we should have learned (but we did not) |
Luciano Rodrigo Lopes, João Henrique Campos, Alison Felipe Alencar Chaves |
4 |
[GO] |
2021―Aug―12 |
Associação entre o uso excessivo de álcool e fibrilação atrial em tempos de pandemia da Covid-19: uma investigação necessária |
Guilherme Brasil Grezzana, Airton Tetelbom Stein |
5 |
[GO] |
2021―Aug―05 |
Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial |
Rafael Leite Pacheco, Hugo Mamede, Denusa Wiltgen, Airton Stein |
6 |
[GO] |
2021―Jun―04 |
Análise epidemiológica de 9.897 óbitos por COVID-19 no período de março a maio de 2020, no Brasil |
Daniele França Dos Santos, Isabella Pereira Rosa De Castro, Claudacy Pessoa Monte Santo, Viviane Pereira Santos, Fabianna Fonseca de Oliveira Figueiredo, Caroline Ferreira Guerreiro |
7 |
[GO] |
2021―Jun―02 |
Are some physicians afraid of the COVID-19 vaccines? A tale of motivated reasoning |
Luis Cláudio Lemos Correia, João de Deus Barreto Segundo |
8 |
[GO] |
2021―Mar―12 |
Systemic Corticosteroids in COVID-19: Critical Appraisal of the WHO Meta-analysis |
Sérgio Renato Da Rosa Decker, Eduardo Gehling Bertoldi |
9 |
[GO] |
2021―Mar―09 |
Evidence, Experts and Systematic Reviews. Has COVID-19 changed their importance? |
Ricardo Maia Ferreira |
10 |
[GO] |
2021―Mar―04 |
What is the evidence in favor of herd immunity for the COVID-19 pandemics? |
Alison Felipe Alencar Chaves |
11 |
[GO] |
2020―Aug―27 |
Do in vitro ao in vivo: a eficácia da cloroquina no tratamento da COVID-19 |
Filipe Mosca Guerra |
12 |
[GO] |
2020―Aug―25 |
Potential treatments for COVID-19 are not parachutes - avoiding a pandemic of medical reversals |
Alison Felipe Alencar Chaves, Felipe Nogueira |
13 |
[GO] |
2020―Jul―24 |
Do pandemics justify non-evidence-based therapies? |
Luís Cláudio Lemos Correia, John Mandrola |
14 |
[GO] |
2020―Jul―16 |
An immunization program against the COVID-19 infodemic |
Luis Cláudio Correia, João de Deus Barreto Segundo |
15 |
[GO] |
2020―Jul―07 |
Ensaios clínicos são mais difíceis de serem conduzidos em covid-19 do que em outras condições? |
Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Raphael Einsfeld Simões Ferreira, Rachel Riera |
16 |
[GO] |
2020―Jul―06 |
Physicians’ preference towards the non-evidence based hydroxychloroquine treatment for COVID-19: the pandemic effect |
Luis Claudio Correia, João Ricardo Pinto Lopes, Flávia Barreto Garcez, Edmond Le Campion, Guilherme Barcellos, José Augusto Barreto-Filho |
17 |
[GO] |
2020―May―08 |
Using resources wisely in the COVID-19 pandemic: an international list of Choosing Wisely recommendations |
Karen Born, Wendy Levinson, Luis Claudio Correia, Sandra Vernero |
18 |
[GO] |
2020―May―08 |
Hydroxychloroquine for the treatment of COVID-19: an approach based on the philosophy of science and heuristics |
Davi Jorge Fontoura Solla |
19 |
[GO] |
2020―Apr―02 |
Why COVID-19 trials should be blinded (as any other one) |
Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina De Oliveira Cruz Latorraca, Rachel Riera |
20 |
[GO] |
2020―Apr―01 |
Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review |
Rafael Leite Pacheco, Rachel Riera |